Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism
about
The role of the ribosome in the regulation of longevity and lifespan extensionProhibitin-mediated lifespan and mitochondrial stress implicate SGK-1, insulin/IGF and mTORC2 in C. elegansMechanisms of aging-related proteinopathies in Caenorhabditis elegansCytoplasmic mRNA turnover and ageingFOXO/DAF-16 Activation Slows Down Turnover of the Majority of Proteins in C. elegans.In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.Altered proteostasis in aging and heat shock response in C. elegans revealed by analysis of the global and de novo synthesized proteomeDAF-16 target identification in C. elegans: past, present and future.Reduced insulin/insulin-like growth factor signaling decreases translation in Drosophila and mice.Increased Protein Stability and Decreased Protein Turnover in the Caenorhabditis elegans Ins/IGF-1 daf-2 MutantThe ubiquitin proteasome system in Caenorhabditis elegans and its regulation.MDL-1, a growth- and tumor-suppressor, slows aging and prevents germline hyperplasia and hypertrophy in C. elegans.RNA surveillance via nonsense-mediated mRNA decay is crucial for longevity in daf-2/insulin/IGF-1 mutant C. elegansE4 ligase-specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosisLC-MS proteomics analysis of the insulin/IGF-1-deficient Caenorhabditis elegans daf-2(e1370) mutant reveals extensive restructuring of intermediary metabolism.Gene expression signatures of human cell and tissue longevity.The Autophagoproteasome a Novel Cell Clearing Organelle in Baseline and Stimulated Conditions.UPS Activation in the Battle Against Aging and Aggregation-Related Diseases: An Extended Review.Immunohistochemical analysis reveals variations in proteasome tissue expression in C. elegansA proteomic atlas of insulin signalling reveals tissue-specific mechanisms of longevity assurance.Mitochondrial ubiquinone-mediated longevity is marked by reduced cytoplasmic mRNA translation
P2860
Q26770848-49564AE4-A364-4EE7-B0AD-86C6146FB5D8Q27346904-F230FD86-FF44-4E90-BBA6-C1298A605565Q28077338-39C76806-AB11-4E53-A390-DC3CF1A80E48Q28081605-5896B365-4ECA-4CC3-95FE-CB861CD8D3DEQ33698052-D1D4ACEA-C61C-4CC4-BA8D-98F360E7B4B8Q33841800-CB435498-0EC9-4EFE-9D1A-EA5B6155B266Q34038251-C658A633-2CF8-47D1-B308-841B18D34AF8Q35182652-39233758-0421-4E5A-AFC8-6BB88704CFB8Q37121889-C622A955-1EB4-4FDF-B8D6-161E37852EF4Q37410501-CC211A9E-C6CE-4B83-899C-3F3D005A1C57Q37587829-2BCFE1F4-7126-4E49-9887-9893DF52319DQ37671514-2BBA0F50-D4BA-4419-B038-76A82FBFF96BQ37695384-14B246DA-BEF0-4BA4-BA34-DF8BC6B00978Q37698652-854A2E6A-830E-4611-A5F9-A6F7270B1DA5Q37714269-CB1F4FD0-6ECA-47C1-928B-7CC2D0E1B54BQ38673042-B8652F93-D3A0-414C-901C-7DB6FBB68BEAQ38753705-5D6D43C7-CD3C-423D-BC79-B3228E247C1CQ38950512-EB8B660E-DB09-4550-A674-23F1BD802D31Q41444639-75B2B13C-628F-48CF-8A93-C6BF05EE6FF4Q41676470-A41FF339-258D-4BF6-A2E1-5965186910B8Q58781228-87143B68-9BE7-41E4-AB4B-888E2CAE1649
P2860
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism
@en
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism.
@nl
type
label
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism
@en
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism.
@nl
prefLabel
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism
@en
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism.
@nl
P2093
P2860
P356
P1476
Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism
@en
P2093
Alyson W Macinnes
Annemieke Kolkman
Arjan B Brenkman
Dorien S Snijders
Edwin C A Stigter
Gerdine J Stout
Hendrik C Korswagen
Klaas W Mulder
Marco C Betist
Niels J F van den Broek
P2860
P356
10.1038/MSB.2013.35
P577
2013-07-02T00:00:00Z